Company Name: PTC Therapeutics, Inc.
PTC Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in the development of orally administered small molecule therapeutics designed to target post-transcriptional control processes. The company’s therapeutic areas include infectious diseases, oncology and rare disorders. The company’s lead product candidate is designed to treat patients with genetic disorders due to a nonsense mutation and is being developed to treat nonsense mutation cystic fibrosis (nmCF) and nonsense mutation Duchenne muscular dystrophy (nmDMD).
Ticker Symbol: PTCT (NASDAQ)
Company Website: www.ptcbio.com
Social Media: PTC Therapeutics LinkedIn
Headquarters: South Plainfield, New Jersey